Matthew Breyer

Company: Janssen

Job title: Former Distinguished Scientist, Cardiovascular & Metabolism Discovery Research

Seminars:

Panel Discussion: Addressing the Unmet Medical Needs in CKD: Defining the Residual Risks & Pathways Forward 8:30 am

Examine the key challenges in identifying CKD patients who continue to face unmet medical needs despite advances in therapy Explore how biomarkers and clinical data can highlight patients with residual risk, who remain at risk for disease progression. What is needed to establish standardized criteria for identifying these high-risk patients? Which pathways and modes of…Read more

day: Day Two AM

Translating OMICS & Real-World Evidence into Meaningful Insights for Target Discovery & Clinical Trial Design 8:00 am

The integration of OMICS data and real-world evidence is transforming drug development. With the increasing volume of CKD data generated through OMICS technologies and real-world evidence studies, there is a critical need to translate this information into actionable insights. This workshop will explore how to leverage OMICS findings to enhance our understanding of disease mechanisms…Read more

day: Pre-Conference Workshop A